CA3124725A1 - Methods of treatment of inflammatory conditions and associated infections - Google Patents

Methods of treatment of inflammatory conditions and associated infections Download PDF

Info

Publication number
CA3124725A1
CA3124725A1 CA3124725A CA3124725A CA3124725A1 CA 3124725 A1 CA3124725 A1 CA 3124725A1 CA 3124725 A CA3124725 A CA 3124725A CA 3124725 A CA3124725 A CA 3124725A CA 3124725 A1 CA3124725 A1 CA 3124725A1
Authority
CA
Canada
Prior art keywords
lactobacillus
subject
condition
inflammation
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3124725A
Other languages
English (en)
French (fr)
Inventor
Wayne FINLAYSON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Servatus Ltd
Original Assignee
Servatus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2018903822A external-priority patent/AU2018903822A0/en
Application filed by Servatus Ltd filed Critical Servatus Ltd
Publication of CA3124725A1 publication Critical patent/CA3124725A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA3124725A 2018-10-10 2019-10-10 Methods of treatment of inflammatory conditions and associated infections Pending CA3124725A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
AU2018903822A AU2018903822A0 (en) 2018-10-10 Compositions and methods of treatment of inflammatory conditions and infections
AU2018903822 2018-10-10
AU2018903823A AU2018903823A0 (en) 2018-10-10 Compositions and methods of treatment of conditions of the gastrointestinal tract
AU2018903823 2018-10-10
AU2019901175A AU2019901175A0 (en) 2019-04-05 Compositions and methods of treatment of conditions of the gastrointestinal tract
AU2019901175 2019-04-05
AU2019901176A AU2019901176A0 (en) 2019-04-05 Compositions and methods of treatment of inflammatory conditions and associated infections
AU2019901176 2019-04-05
PCT/AU2019/051092 WO2020073088A1 (en) 2018-10-10 2019-10-10 Methods of treatment of inflammatory conditions and associated infections

Publications (1)

Publication Number Publication Date
CA3124725A1 true CA3124725A1 (en) 2020-04-16

Family

ID=70163621

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3124725A Pending CA3124725A1 (en) 2018-10-10 2019-10-10 Methods of treatment of inflammatory conditions and associated infections

Country Status (8)

Country Link
US (1) US20210338749A1 (https=)
EP (1) EP3863656A4 (https=)
JP (1) JP2022504792A (https=)
CN (1) CN114206362A (https=)
AU (1) AU2019356524A1 (https=)
CA (1) CA3124725A1 (https=)
SG (1) SG11202103567RA (https=)
WO (1) WO2020073088A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4255456A4 (en) * 2020-12-01 2024-09-25 Servatus Ltd METHODS TO IMPROVE SLEEP QUALITY
EP4259150A4 (en) * 2020-12-09 2024-12-25 Servatus Ltd COMBINATION THERAPY FOR INFLAMMATORY JOINT DISEASES
EP4387640A1 (en) * 2021-08-19 2024-06-26 Société des Produits Nestlé S.A. Postbiotic
EP4387639A1 (en) * 2021-08-19 2024-06-26 Société des Produits Nestlé S.A. Postbiotic
US12185767B2 (en) * 2021-11-05 2025-01-07 Trillium Medical Products, LLC Infused undergarment
AU2022400465A1 (en) * 2021-12-02 2024-07-18 Servatus Ltd Methods for the treatment of constipation
CN115725469B (zh) * 2022-11-28 2024-05-14 广西大学 一株副干酪乳杆菌及其应用
WO2024160209A1 (zh) * 2023-02-01 2024-08-08 北京三元食品股份有限公司 一株母乳来源的鼠李糖乳酪杆菌及应用
CN117448227B (zh) * 2023-10-31 2024-09-20 西南大学 一株副干酪乳酪杆菌及其在预防和治疗痤疮中的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
ITMI20032391A1 (it) * 2003-12-05 2005-06-06 Consiglio Nazionale Ricerche Olive da mensa contenenti microrganismi probiotici.
CN102014888A (zh) * 2007-07-03 2011-04-13 达努塔·克鲁谢夫斯卡 α-酮戊二酸的新医药用途
JP4876262B2 (ja) * 2008-10-24 2012-02-15 防衛省技術研究本部長 抗炎症効果を有する新規植物性乳酸菌株、該菌株を用いた炎症性腸疾患又は慢性下痢症に対する予防及び治療剤、抑制剤並びに添加剤
WO2011082218A1 (en) * 2009-12-31 2011-07-07 Ira Milton Trachtman Compositions and method for treatment and prophylaxis of inflammatory bowel disease
US9492487B2 (en) * 2010-02-01 2016-11-15 Matthew Ryan Garner Microbial product containing multiple microorganisms
ES2660775T3 (es) * 2011-05-16 2018-03-26 Belano Medical Ag Nuevas bacterias del ácido láctico y composiciones que las contienen contra los resfriados bacterianos
WO2014172758A1 (en) * 2013-04-23 2014-10-30 International Marketing Partnerships Pty Ltd Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same
ITMI20130793A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
KR20150023132A (ko) * 2013-08-23 2015-03-05 (주) 아이투비 아토피 피부용 조성물
CN104000184A (zh) * 2013-12-09 2014-08-27 胡安然 一种调理萎缩性胃炎的膳食
WO2016179639A1 (en) * 2015-05-13 2016-11-17 Markson Ro Probiotic compositions and uses thereof
CN106860441B (zh) * 2017-02-10 2019-12-31 中国医学科学院医药生物技术研究所 4-氧代-2-丁烯酰胺衍生物在制备抑菌剂中的应用
KR101917497B1 (ko) * 2017-02-18 2018-11-09 박병희 신규한 락토바실러스 부크네리 및 이의 용도
TWI607758B (zh) * 2017-03-07 2017-12-11 景岳生物科技股份有限公司 改善乾癬症狀的副乾酪乳桿菌菌株ｇｍｎｌ－６５３及其組合物
AU2018251616B2 (en) * 2017-04-11 2025-04-03 Servatus Ltd Methods for the treatment of inflammation and inflammatory conditions
EP3764807A4 (en) * 2018-03-14 2021-11-03 Sustainable Community Development, LLC PROBIOTIC AND FOOD ADDITIVE COMPOSITION

Also Published As

Publication number Publication date
EP3863656A4 (en) 2022-06-29
EP3863656A1 (en) 2021-08-18
CN114206362A (zh) 2022-03-18
WO2020073088A1 (en) 2020-04-16
SG11202103567RA (en) 2021-05-28
US20210338749A1 (en) 2021-11-04
AU2019356524A1 (en) 2021-05-13
JP2022504792A (ja) 2022-01-13

Similar Documents

Publication Publication Date Title
US20210338749A1 (en) Methods of treatment of inflammatory conditions and associated infections
US20250032563A1 (en) Methods for the treatment of inflammation and inflammatory conditions
US20230149481A1 (en) Combination therapy for inflammatory bowel disease
CN102333534B (zh) 用于治疗胃溃疡和十二指肠溃疡的包括质子泵抑制剂及益生元的药物组合物
CN120607980A (zh) 菌株和组合物
US20180125902A1 (en) Use of antibiotics with specific therapeutic activities combined with the simultaneous use of lactobacilli and/or bifidobacteria with a non-transferable antibiotic resistance, having the same therapeutic indication
CN114949202A (zh) 一种益生菌和蛋白质的组合物及其抗幽门螺旋杆菌的应用
US20240033309A1 (en) Combination therapy for inflammatory disorders of the joints
US11020440B2 (en) Probiotic for the treatment of psoriasis
WO2025248095A1 (en) Probiotic strain lactobacillus gasseri for vaginal infections
CN119530074A (zh) 一种格氏乳杆菌m17c及其组合物
CN119530073A (zh) 一种卷曲乳杆菌x25b及其用途

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220727

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250829

U13 Renewal or maintenance fee not paid

Free format text: ST27 STATUS EVENT CODE: N-6-6-U10-U13-U300 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO MAINTENANCE FEE NOTICE

Effective date: 20251029

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251121